Li Peng
- Molecular Biology top 2%
- Cancer Research top 0.5%
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 10%
- Surgery
- Co-authors
- Guan‐Cheng LiXiaoqing YuanBinyuan JiangChaoyang ZhangXuedong ZhouNan ZhouHaiwei YangJie Han
- Topics
- Cancer-related molecular mechanisms research (30 papers)RNA modifications and cancer (21 papers)MicroRNA in disease regulation (17 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Li Peng
126 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Molecular Biology 2.7k
- Cancer Research 1.9k
- Pulmonary and Respiratory Medicine 448
- Oncology 286
- Surgery 238
Countries citing papers authored by Li Peng
This map shows the geographic impact of Li Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Peng more than expected).
Fields of papers citing papers by Li Peng
This network shows the impact of papers produced by Li Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Peng. The network helps show where Li Peng may publish in the future.
Co-authorship network of co-authors of Li Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Li Peng. A scholar is included among the top collaborators of Li Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Peng. Li Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 7 | |
| 5 | 2 | |
| 6 | 8 | |
| 7 | 3 | |
| 8 | 28 | |
| 9 | FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associationsbreakdown → | 260 |
| 10 | 7 | |
| 11 | 2 | |
| 12 | 32 | |
| 13 | 109 | |
| 14 | 34 | |
| 15 | 83 | |
| 16 | 42 | |
| 17 | 6 | |
| 18 | 7 | |
| 19 | 47 | |
| 20 | 36 |
About Li Peng
Li Peng is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 135 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (30 papers), RNA modifications and cancer (21 papers) and MicroRNA in disease regulation (17 papers). The work is most often cited by research in Cancer Research (1.9k citations), Molecular Biology (2.7k citations) and Oral Surgery (110 citations). Li Peng has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Guan‐Cheng Li, Xiaoqing Yuan, Binyuan Jiang, Chaoyang Zhang, Xuedong Zhou, Nan Zhou, Haiwei Yang, Jie Han, Pengchao Li and Jingzi Wang. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.